Unable to display view head.php file not found.
The Figure shows the baseline patient characteristics,[99] which are almost indistinguishable from those in RE-LY,[96]including the CHADS2 score, which was a mean of 2.1, with about one third of the patients having a score ≥3.
Reiffel JA. Am J Med 2013; 126: 00-00.
[96] Connolly SJ, Ezekowitz MD, Yusuf S, et al; RE-LY Steering Committee and Investigators. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139-1151.
[99] Granger CB, Alexander JH, McMurray JV, et al; the ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981-992.